Chimerix Inc (CMRX)
1.00
+0.01
(+1.01%)
USD |
NASDAQ |
Nov 05, 10:23
Chimerix Free Cash Flow: -67.84M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | -67.84M |
| March 31, 2024 | -64.44M |
| December 31, 2023 | -69.18M |
| September 30, 2023 | -74.58M |
| June 30, 2023 | -49.57M |
| March 31, 2023 | -45.78M |
| December 31, 2022 | -46.94M |
| September 30, 2022 | -60.99M |
| June 30, 2022 | -83.34M |
| March 31, 2022 | -85.61M |
| December 31, 2021 | -100.14M |
| September 30, 2021 | -75.14M |
| June 30, 2021 | -68.20M |
| March 31, 2021 | -63.24M |
| December 31, 2020 | -36.10M |
| September 30, 2020 | -30.53M |
| June 30, 2020 | -64.34M |
| March 31, 2020 | -70.34M |
| December 31, 2019 | -75.34M |
| September 30, 2019 | -80.18M |
| June 30, 2019 | -50.96M |
| March 31, 2019 | -51.18M |
| December 31, 2018 | -53.91M |
| September 30, 2018 | -57.83M |
| Date | Value |
|---|---|
| June 30, 2018 | -56.28M |
| March 31, 2018 | -55.20M |
| December 31, 2017 | -50.28M |
| September 30, 2017 | -47.81M |
| June 30, 2017 | -49.61M |
| March 31, 2017 | -49.42M |
| December 31, 2016 | -64.66M |
| September 30, 2016 | -88.62M |
| June 30, 2016 | -100.98M |
| March 31, 2016 | -112.00M |
| December 31, 2015 | -102.10M |
| September 30, 2015 | -85.55M |
| June 30, 2015 | -71.92M |
| March 31, 2015 | -57.85M |
| December 31, 2014 | -48.10M |
| September 30, 2014 | -37.76M |
| June 30, 2014 | -31.03M |
| March 31, 2014 | -28.87M |
| December 31, 2013 | -25.75M |
| September 30, 2013 | -23.55M |
| June 30, 2013 | -6.074M |
| March 31, 2013 | -3.187M |
| December 31, 2012 | -2.002M |
Free Cash Flow Range, Past 5 Years
-100.14M
Minimum
Dec 2021
-30.53M
Maximum
Sep 2020
-64.82M
Average
-67.84M
Median
Jun 2024
Free Cash Flow Benchmarks
| SIGA Technologies Inc | 73.77M |
| Abbott Laboratories | 6.486B |
| Emergent BioSolutions Inc | 37.60M |
| Tonix Pharmaceuticals Holding Corp | -75.58M |
| Geovax Labs Inc | -23.00M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -17.68M |
| Cash from Investing (Quarterly) | 14.36M |
| Cash from Financing (Quarterly) | -0.042M |
| Free Cash Flow Per Share (Quarterly) | -0.1981 |
| Free Cash Flow to Equity (Quarterly) | -17.75M |
| Free Cash Flow Yield | -76.13% |